Variety of At-Track Fundraising Auctions During Mobil 1 Twelve Hours of Sebring Race Week
Foundation’s 10th Year as IMSA ‘Proud Charity’ Yielding Fundraising, Awareness Benefits
Week Starts With Visit to Arnold Palmer Children’s Hospital in Orlando
CHATTANOOGA, Tenn. (March 11, 2019) – It’s one of the biggest weeks of the year for the Austin Hatcher Foundation for Pediatric Cancer, because it’s also one of the biggest weeks of the sports car racing season, culminated by Saturday’s 67th Annual Mobile 1 Twelve Hours of Sebring at famed Sebring International Raceway.
The synergy results from the 10th year of Austin Hatcher Foundation’s status as an official “Proud Charity” of the International Motor Sports Association (IMSA), North America’s premier sports car competition sanctioning body; Sebring is the second event on the IMSA WeatherTech SportsCar Championship schedule, following January’s highly successful Rolex 24 At DAYTONA.
CHATTANOOGA, Tenn. (March 7, 2019) - The Austin Hatcher Foundation welcomes three new board members to their growing leadership team - Wanda Phipatanakul, MD, MS of Boston, Angie Burton of Knoxville, and Clay Watson of Chattanooga.
CHATTANOOGA, Tenn. (March 5, 2019) - The Austin Hatcher Foundation for Pediatric Cancer has launched an innovative cognitive program and study using driving simulators. The program allows pediatric cancer patients and their siblings to participate in fun, therapeutic activities while providing valuable information about children’s cognitive control skills. Driving simulators have been used around the world to improve the cognitive and executive function of intact and injured brains.
Some childhood cancer survivors develop learning problems, called cognitive impairments, as a result of the disease or cancer treatment. These problems affect cognitive control skills such as paying attention, how fast the brain works, memory, hand-eye coordination, and being able to stop and think. “Cancer treatment is especially aggressive for young children, and we’re grateful that the survival rate has increased to 80%. However, because treatment occurs while children are still growing, some side effects...